Comorbidity and medication in REM sleep behavior disorder: a multicenter case-control study

Birgit Frauscher¹, Poul Jennum, Yo-El S Ju+26

• ¹From the Department of Neurology (B.F., D.G., T.M., B.H.), Innsbruck Medical University, Austria; Danish Center for Sleep Medicine (P.J.), University of Copenhagen, Denmark; Department of Neurology (Y.-E.S.J.), Washington University School of Medicine, St Louis, MO; Department of Neurology (R.B.P.), McGill University, Montreal General Hospital, Canada; Unité des Pathologies du Sommeil (I.A., S.L.-S.), Hôpital Pitié-Salpêtrière, APHP, and Inserm U975-CRICM-Pierre and Marie Curie University, Paris; Sleep Unit (V.C.D.C., Y.D.), Department of Neurology, Hôpital Gui de Chauliac, Montpellier, INSERM U1061, Montpellier, France; Sleep Disorders Center (M.L.F.), Department of Neurosciences, University of Turin, Italy; UFR Medecine (M.L.F.), EA 7280, University Clermont 1, France; Sleep Disorders Center (L.F.-S., M.Z.), Università Vita-Salute San Raffaele, Milan, Italy; Neurology Service (A.I., J.S.), Hospital Clinic de Barcelona, IDIBAPS, CIBERNED, Spain; Department of Neurology (M.M.), Dokkyo Medical University School of Medicine, Tochigi; Department of Neurology (T.M.), Dokkyo Medical University Koshigaya Hospital, Saitama, Japan; Centre d'Études Avancées en Médecine du Sommeil (J.Y.M.), Hôpital du Sacré-Coeur de Montréal, Canada; Philipps-Universität (W.O., M.U.), Marburg, Germany; Neuroepidemiology Research Unit (A.P., C.W.), Research Institute of the McGill University Health Centre, Montreal; Canada; Unit of Sleep Medicine (P.P., M.T., R.M.), National Institute of Neurology IRCCS, C. Mondino Foundation, Pavia; Sleep Center (M.P.), Department of Cardiovascular and Neurological Sciences, University of Cagliari, Italy; Department of Neurology (K.S.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; Department of Neurology (M.U.), Saarland University, Homburg/Saar; and Hephata Klinik (G.M.), Schwalmstadt-Treysa, Germany.